ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $100,000 | -79.2% | 153,309 | +0.6% | 0.00% | -100.0% |
| Q3 2016 | $480,000 | +1.9% | 152,347 | +0.0% | 0.00% | 0.0% |
| Q2 2016 | $471,000 | -9.1% | 152,291 | +6.5% | 0.00% | 0.0% |
| Q1 2016 | $518,000 | -20.7% | 143,010 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $653,000 | -22.9% | 140,697 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $847,000 | -23.5% | 139,070 | +8.3% | 0.00% | 0.0% |
| Q2 2015 | $1,107,000 | +4931.8% | 128,380 | +2456.9% | 0.00% | – |
| Q1 2015 | $22,000 | +266.7% | 5,021 | +35.3% | 0.00% | – |
| Q4 2014 | $6,000 | -14.3% | 3,711 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | -36.4% | 3,711 | +9.7% | 0.00% | – |
| Q2 2014 | $11,000 | – | 3,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |